***My SPCL PPS calculation on projected revenue of-Pixel

New Post Public Reply Private Reply Replies (0) Message Board
Pugilista
***My SPCL PPS calculation on projected revenue of-Pixel Mags***

We all are waiting for AUDITED FINS to be drop at any time. Some expecting annual revenue to be at $5 Million, some $10 Million, some $30 Million, some $48 Million and some saying up to $70 Million. We all soon will come to know the REAL number when company will release audited fins very shortly. Here are my PPS calculation.

5 Million Revenue / 1.83 Billion Current OS shares = 0.0027. 0.0027 x 12 (P.E.G.) = 0.032 EXPECTED PPS

10 Million Revenue / 1.83 Billion Current OS shares = 0.0055. 0.0055 x 12 (P.E.G.) = 0.066 EXPECTED PPS

30 Million Revenue / 1.83 Billion Current OS shares = 0.0163. 0.0163 x 12 (P.E.G.) = 0.195 EXPECTED PPS

60 Million Revenue / 1.83 Billion Current OS shares = 0.0327. 0.0327 x 12 (P.E.G.) = 0.392 EXPECTED PPS

Today we are at .0058.

If Pixel Mags Inc report annual revenue of $5 Million, then from .0058 to 0.032. That is gain of around 600%.

If Pixel Mags Inc report annual revenue of $30 Million, then from .0058 to 0.195. That is gain of around 4000%.

If Pixel Mags Inc report annual revenue of $60 Million, then from .0058 to 0.392. That is gain of around 8000%.

Today, UBER is leader in their industry and their market valuation today is >$65 BILLION, Yes BILLIONS.

Pixel Mags Inc is ALSO a leader in their industry and once we are on NASDAQ/NYSE I am expecting Pixel Mags valuation to be in BILLIONS of DOLLARS as well. That is my expectation.

REMEMBER ALL - It was posted by many here on this board that VERT Capital does transaction ONLY with companies whose revenue is more then $10M. ENJOY.

EVERYONE CAN DO THEIR MATH. Good Luck. Everything written here is my opinion. Do not buy or sell on what I write or say.

Must read below post from ‘xyz1002’

Solaris Power Cells, Inc (SPCL) Stock Research Links

SPCL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Lumexa Imaging's Investor Conference Push: Any Real Substance?

Updated Category News Views 132

Lumexa Imaging just dropped a line on Feb 17, 2026, about their upcoming investor conference gigs. Sure, they're strutting into multiple events—Raymond James in Orlando, Leerink Partners in Miami, and Barclays back-to-back days after that. But here’s the kicker: are these talks really worth the buzz? In a space where outpatient imaging claims to be kingpin, you’ve...

Continue Reading
Current Landscape of US Stock Futures Amid Rate Cuts

Updated Category News Views 173

Insights on the Current Stability of U.S. Stock Futures During Asian trading hours, U.S. stock index futures have held steady. Investors are hoping for interest rate cuts as the Federal Reserve's next meeting approaches. This meeting is expected to reveal a significant easing cycle that many in the market are eagerly anticipating. Even with strong reports on consumer and...

Continue Reading
Wispr Flow Revolutionizes Voice Dictation Across Platforms

Updated Category News Views 469

Wispr Flow Expands Its Reach in Voice Dictation Technology In a world where speed and efficiency are paramount, Wispr, known as The Voice Interface Company, is revolutionizing the way we interact with technology. With the recent launch of Wispr Flow for Windows, this innovative voice productivity tool is now accessible to users across both Mac and Windows platforms,...

Continue Reading
MintMiner: Your Ultimate Gateway to Cloud Mining Success

Updated Category News Views 197

Unlocking the Future of Cloud Mining with MintMiner In today's uncertain financial landscape, MintMiner presents an innovative solution for anyone looking to tap into the world of digital assets. As global financial systems face challenges, MintMiner offers a unique platform that makes cloud mining accessible, straightforward, and profitable. Understanding Cloud Mining...

Continue Reading
GT Biopharma's Strategic Move: Withdrawal of S-1 Registration

Updated Category News Views 100

GT Biopharma's Strategic Withdrawal of Form S-1 Registration GT Biopharma, Inc. (NASDAQ: GTBP) recently made headlines with its request for withdrawal of a Form S-1 registration statement. This decision marks a crucial moment for the company, based in San Francisco, known for its innovative approach in the immuno-oncology sector. GT Biopharma focuses on the development of...

Continue Reading